RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      의료과오소송에 있어서 설명・동의에 관한 소고

      한글로보기

      https://www.riss.kr/link?id=A104728902

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      In recent times, it is generally recognized that patients must ensure right of self–determination, right to know, consent competency in medical practice.
      However, in reality, the doctor is expert who has professional knowledge on the medicine field, whereas patients are layperson about medicine. Under these circumstances, it is natural that patients should be in a disadvantageous position in comparison with doctor. In this situation, it is required for the patients to ask various questions about disease, to advocate patient’s right to know. Also, doctor must make sufficient explanations to guarantee patients’right. Doctor should not manage to escape liability by formal and insincere questions. By setting up a good and trustful doctor–patient relationship, we can prohibit defensive medicine executed by a doctor. At the same time,we can foster more desirable treatment milieu between them. Informed consent is derived from to secure patient’s or participant’s right to self–determination substantially in the field of medical practice and medical research. On the other point of view, some opinions show that it is desirable to restrict informed consent to attenuate psychological burden, in case of participating medical treatment and medical research for the sake of securing patient’s or participant’s self–determination effectively. But this is superficial viewpoint. This is dimensionally different problem. Henceforth, That problem can practically be deduced a conclusion, vice versa, in real medical practice. In conclusion,it should be desirable to acquire informed consent from patients, except for the inevitable circumstances. To this point of view, we should solve this difficult problem rationally.
      번역하기

      In recent times, it is generally recognized that patients must ensure right of self–determination, right to know, consent competency in medical practice. However, in reality, the doctor is expert who has professional knowledge on the medicine field,...

      In recent times, it is generally recognized that patients must ensure right of self–determination, right to know, consent competency in medical practice.
      However, in reality, the doctor is expert who has professional knowledge on the medicine field, whereas patients are layperson about medicine. Under these circumstances, it is natural that patients should be in a disadvantageous position in comparison with doctor. In this situation, it is required for the patients to ask various questions about disease, to advocate patient’s right to know. Also, doctor must make sufficient explanations to guarantee patients’right. Doctor should not manage to escape liability by formal and insincere questions. By setting up a good and trustful doctor–patient relationship, we can prohibit defensive medicine executed by a doctor. At the same time,we can foster more desirable treatment milieu between them. Informed consent is derived from to secure patient’s or participant’s right to self–determination substantially in the field of medical practice and medical research. On the other point of view, some opinions show that it is desirable to restrict informed consent to attenuate psychological burden, in case of participating medical treatment and medical research for the sake of securing patient’s or participant’s self–determination effectively. But this is superficial viewpoint. This is dimensionally different problem. Henceforth, That problem can practically be deduced a conclusion, vice versa, in real medical practice. In conclusion,it should be desirable to acquire informed consent from patients, except for the inevitable circumstances. To this point of view, we should solve this difficult problem rationally.

      더보기

      참고문헌 (Reference)

      1 안선화, "환자의 알권리와 자기결정" 한국의료윤리학회 12 (12): 153-164, 2009

      2 송영민, "환자의 동의능력의 판단기준" 법학연구소 (48) : 577-602, 2010

      3 김선중, "최신 실무 의료과오소송법" 박영사 2005

      4 이득환, "정신의료에 대한 민사법적 고찰" 경북대학교 대학원 2008

      5 김민중, "의사책임 및 의사법의 발전에 관한 최근의 동향" 9 : 1993

      6 노상엽, "의료행위 자기결정권과 그 한계" 가톨릭대학교 법학연구소 (5) : 2010

      7 울산대학교 산학협력단, "의료기관 이용자 권리보호 실태 및 개선방안 연구" 국가인권위원회 2009

      8 石原 明, "法と生命倫理20講" 日本評論社 2004

      9 田坂 晶, "治療行爲に対する患者の同意能力に関する一考察 – アメリカ合衆国との比較法的考察–" 60 (60): 2008

      10 甲斐克則, "レクチャー生命倫理と法" 法律文化社 2010

      1 안선화, "환자의 알권리와 자기결정" 한국의료윤리학회 12 (12): 153-164, 2009

      2 송영민, "환자의 동의능력의 판단기준" 법학연구소 (48) : 577-602, 2010

      3 김선중, "최신 실무 의료과오소송법" 박영사 2005

      4 이득환, "정신의료에 대한 민사법적 고찰" 경북대학교 대학원 2008

      5 김민중, "의사책임 및 의사법의 발전에 관한 최근의 동향" 9 : 1993

      6 노상엽, "의료행위 자기결정권과 그 한계" 가톨릭대학교 법학연구소 (5) : 2010

      7 울산대학교 산학협력단, "의료기관 이용자 권리보호 실태 및 개선방안 연구" 국가인권위원회 2009

      8 石原 明, "法と生命倫理20講" 日本評論社 2004

      9 田坂 晶, "治療行爲に対する患者の同意能力に関する一考察 – アメリカ合衆国との比較法的考察–" 60 (60): 2008

      10 甲斐克則, "レクチャー生命倫理と法" 法律文化社 2010

      11 樋口範雄, "ケース・スタディ生命倫理と法, マーシャ・ギャリソン, In 自己決定權を飼いならすために – 自己決定權再考" 有斐閣 2004

      12 Thomas G. Gutheil, "Clinical Handbook of Psychiatry and the Law" McGraw–Hill Book Company 1982

      13 Janet L. Dolgin, "Bioethics and the law(2nd ed)" Aspen Publishers 2009

      14 건강세상네트워크, "(환자가 고발하는)환자권리 피해 사례(제1회 환자권리주간 행사 : 환자, ‘권리’를 말하다, 일시: 2008.5.30.)"

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.31 0.31 0.49
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.54 0.5 0.606 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼